Molecular and clinical landscape of ESR1 and PIK3CA co-mutations in HR+ MBC

Evidence-based insights into dual pathway resistance to optimize breast cancer therapy

INDICATION
Breast
BIOMARKER
ESR1

 

Real-world overall survival by mutation status

 

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Three abstract data distributions displayed as shapes made of small, colored squares.

Sacituzumab govitecan and tumor microenvironment shifts in metastatic triple-negative breast cancer

2026-07-01
CXCL/SPP1 (CS)
Breast
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
A blue grid with dark blue squares forming a descending diagonal path, possibly a heatmap.

Optimizing therapy sequencing for HR+ HER2- metastatic breast cancer

2026-05-26
Breast
HER2
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Unable to determine image content.

ESR1 mutations and copy number loss in breast cancer

2026-05-26
Breast
ESR1